BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26874666)

  • 1. [Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review].
    Sardain H; Lavoué V; Foucher F; Levêque J
    J Gynecol Obstet Biol Reprod (Paris); 2016 Apr; 45(4):315-29. PubMed ID: 26874666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review.
    Sardain H; Lavoue V; Redpath M; Bertheuil N; Foucher F; Levêque J
    Eur J Surg Oncol; 2015 Aug; 41(8):975-85. PubMed ID: 25922209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indications for primary and secondary exenterations in patients with cervical cancer.
    Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
    Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current status and outcomes of pelvic exenteration for recurrent cervical cancer: a systematic review].
    Chen M; Pan L
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):460-5. PubMed ID: 25169641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of locally advanced and recurrent cervical carcinoma: overview on current standard and new developments.
    Höckel M
    Onkologie; 2003 Oct; 26(5):452-5. PubMed ID: 14605461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic pelvic exenteration and laterally extended endopelvic resection for postradiation recurrent cervical carcinoma: Technical feasibility and short-term oncologic outcome.
    Kanao H; Aoki Y; Omi M; Nomura H; Tanigawa T; Okamoto S; Chang EJ; Kurita T; Netsu S; Matoda M; Omatsu K; Matsuo K
    Gynecol Oncol; 2021 Apr; 161(1):34-38. PubMed ID: 33423805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total laparoscopic pelvic exenteration for a laterally recurrent cervical carcinoma with a vesicovaginal fistula that developed after concurrent chemoradiotherapy.
    Kanao H; Aoki Y; Hisa T; Takeshima N
    Gynecol Oncol; 2017 Aug; 146(2):438-439. PubMed ID: 28576262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery.
    Caceres A; Mourton SM; Bochner BH; Gerst SR; Liu L; Alektiar KM; Kardos SV; Barakat RR; Boland PJ; Chi DS
    Int J Gynecol Cancer; 2008; 18(5):1139-44. PubMed ID: 18053063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Outcomes of perisurgery and short-time follow-up of pelvic exenteration for 17 cases with locally recurrent cervical cancer].
    Deng H; Wang JL; Wang ZQ; Li XW; Hu H; Yang B; Zhang XM; Shen K; Guo P; Liang B
    Zhonghua Fu Chan Ke Za Zhi; 2020 Apr; 55(4):259-265. PubMed ID: 32375433
    [No Abstract]   [Full Text] [Related]  

  • 10. Pelvic exenteration for cervix cancer: would additional intraoperative interstitial brachytherapy improve survival?
    Beitler JJ; Anderson PS; Wadler S; Runowicz CD; Hayes MK; Fields AL; Sood B; Goldberg GL
    Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):143-8. PubMed ID: 9212016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for curative pelvic exenterations in patients with recurrent uterine cervical or vaginal cancer.
    Sardain H; Lavoué V; Laviolle B; Henno S; Foucher F; Levêque J
    Int J Gynecol Cancer; 2014 Nov; 24(9):1679-85. PubMed ID: 25254565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome of pelvic exenteration in patients with advanced or recurrent uterine cervical cancer.
    Tanaka S; Nagase S; Kaiho-Sakuma M; Nagai T; Kurosawa H; Toyoshima M; Tokunaga H; Otsuki T; Utsunomiya H; Takano T; Niikura H; Ito K; Yaegashi N
    Int J Clin Oncol; 2014 Feb; 19(1):133-8. PubMed ID: 23404487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative study of the development of a multidisciplinary case conference review methodology to reduce involved margins in pelvic exenteration surgery for recurrent rectal cancer.
    van Ramshorst GH; O'Shannassy S; Brown WE; Kench JG; Solomon MJ
    Colorectal Dis; 2018 Nov; 20(11):1004-1013. PubMed ID: 29920909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative Pelvic Exenteration for Pelvic Recurrence Invading the Sciatic Foramen with Chronic Cutaneous Perineal Fistula after Radical Surgery for Cervical Cancer: A Case Report.
    Bacalbasa N; Balescu I
    Anticancer Res; 2015 Sep; 35(9):4877-80. PubMed ID: 26254382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy prior to pelvic exenteration in patients with recurrent cervical cancer: single institution experience.
    Landoni F; Zanagnolo V; Rosenberg PG; Lopes A; Radice D; Bocciolone L; Aletti G; Parma G; Colombo N; Maggioni A
    Gynecol Oncol; 2013 Jul; 130(1):69-74. PubMed ID: 23474343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic exenteration for carcinoma of the cervix.
    Ingersoll FM; Ulfelder H
    N Engl J Med; 1966 Mar; 274(12):648-51. PubMed ID: 17926376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic assessment improves case selection for exenterative surgery in recurrent cervical and endometrial cancer.
    Heath OM; Bryan SJ; Sohaib A; Barton DPJ
    J Obstet Gynaecol; 2021 Nov; 41(8):1252-1256. PubMed ID: 33646894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-operative radiation therapy after a total lateral extended infralevator exenteration for recurrent cervical cancer.
    Manzour N; Vázquez-Vicente D; Carriles I; Boria F; Chacon E; Chiva L
    Int J Gynecol Cancer; 2021 Aug; 31(8):1188-1189. PubMed ID: 34031133
    [No Abstract]   [Full Text] [Related]  

  • 19. Panniculectomy concurrent with anterior pelvic exenteration for recurrent cervical cancer.
    Richardson DL; Seamon LG; Gong MC; Chapman DM; Cohn DE
    Gynecol Oncol; 2008 Feb; 108(2):449-51. PubMed ID: 18042491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical management of recurrent cervical cancer.
    Selman AE; Copeland LJ
    Yonsei Med J; 2002 Dec; 43(6):754-62. PubMed ID: 12497659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.